Pre- and Post-Treatment Elevation of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome
JAMA Oncol 2022 Sep 01;[EPub Ahead of Print], OH Butt, AY Zhou, PF Caimi, PH Luckett, JK Wisch, PR Derenoncourt, K Lee, GF Wu, MJG de Lima, JL Campian, MJ Frank, JF DiPersio, A Ghobadi, BM AncesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.